Volker Sandig - Search Results

Year	Number of Results
2003	1
2004	1
2005	1
2008	1
2009	3
2010	3
2011	17
2012	6
2013	3
2014	3
2015	1
2016	2
2017	2
2018	2
2019	6
2020	3
2022	1

1

Matrix and backstage: cellular substrates for viral vaccines.

Jordan I, Sandig V. Jordan I, et al. Among authors: sandig v. Viruses. 2014 Apr 11;6(4):1672-700. doi: 10.3390/v6041672. Viruses. 2014. PMID: 24732259 Free PMC article. Review.

2

High-cell-density cultivations to increase MVA virus production.

Vázquez-Ramírez D, Genzel Y, Jordan I, Sandig V, Reichl U. Vázquez-Ramírez D, et al. Among authors: sandig v. Vaccine. 2018 May 24;36(22):3124-3133. doi: 10.1016/j.vaccine.2017.10.112. Epub 2018 Feb 9. Vaccine. 2018. PMID: 29433897 Free PMC article.

3

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Jordan I, Lohr V, Genzel Y, Reichl U, Sandig V. Jordan I, et al. Among authors: sandig v. Microorganisms. 2013 Nov 1;1(1):100-121. doi: 10.3390/microorganisms1010100. Microorganisms. 2013. PMID: 27694766 Free PMC article. Review.

4

Forced Degradation Testing as Complementary Tool for Biosimilarity Assessment.

Dyck YFK, Rehm D, Joseph JF, Winkler K, Sandig V, Jabs W, Parr MK. Dyck YFK, et al. Among authors: sandig v. Bioengineering (Basel). 2019 Jul 21;6(3):62. doi: 10.3390/bioengineering6030062. Bioengineering (Basel). 2019. PMID: 31330921 Free PMC article.

5

A dynamic model linking cell growth to intracellular metabolism and extracellular by-product accumulation.

Ramos JRC, Rath AG, Genzel Y, Sandig V, Reichl U. Ramos JRC, et al. Among authors: sandig v. Biotechnol Bioeng. 2020 May;117(5):1533-1553. doi: 10.1002/bit.27288. Epub 2020 Feb 15. Biotechnol Bioeng. 2020. PMID: 32022250

6

Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode.

Coronel J, Gränicher G, Sandig V, Noll T, Genzel Y, Reichl U. Coronel J, et al. Among authors: sandig v. Front Bioeng Biotechnol. 2020 Jul 2;8:672. doi: 10.3389/fbioe.2020.00672. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32714908 Free PMC article.

7

Fucose-targeted glycoengineering of pharmaceutical cell lines.

Ogorek C, Jordan I, Sandig V, von Horsten HH. Ogorek C, et al. Among authors: sandig v. Methods Mol Biol. 2012;907:507-17. doi: 10.1007/978-1-61779-974-7_29. Methods Mol Biol. 2012. PMID: 22907371

8

Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans.

Dekkers G, Plomp R, Koeleman CA, Visser R, von Horsten HH, Sandig V, Rispens T, Wuhrer M, Vidarsson G. Dekkers G, et al. Among authors: sandig v. Sci Rep. 2016 Nov 22;6:36964. doi: 10.1038/srep36964. Sci Rep. 2016. PMID: 27872474 Free PMC article.

9

Applying Acylated Fucose Analogues to Metabolic Glycoengineering.

Rosenlöcher J, Böhrsch V, Sacharjat M, Blanchard V, Giese C, Sandig V, Hackenberger CPR, Hinderlich S. Rosenlöcher J, et al. Among authors: sandig v. Bioengineering (Basel). 2015 Nov 30;2(4):213-234. doi: 10.3390/bioengineering2040213. Bioengineering (Basel). 2015. PMID: 28952479 Free PMC article.

10

A Deleted Deletion Site in a New Vector Strain and Exceptional Genomic Stability of Plaque-Purified Modified Vaccinia Ankara (MVA).

Jordan I, Horn D, Thiele K, Haag L, Fiddeke K, Sandig V. Jordan I, et al. Among authors: sandig v. Virol Sin. 2020 Apr;35(2):212-226. doi: 10.1007/s12250-019-00176-3. Epub 2019 Dec 12. Virol Sin. 2020. PMID: 31833037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results